CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🛡️

Immunology & Inflammation

107 drugs in pipeline from 10 companies

107

Drugs in Pipeline

10

Companies

9

Upcoming Catalysts

107

Phase 3 Trials

Upcoming Catalysts
4d
KYTXPhase 2

Standard lymphodepletion regimen Phase 2 Results Expected

Standard lymphodepletion regimen25
Apr 15
CT.gov
00%
4d
GILDPhase 2

Tilpisertib Fosmecarbil Phase 2 Results Expected

Tilpisertib Fosmecarbil176
Apr 15
CT.gov
00%
4d
ODYYPhase 2

OD-07656 Phase 2 Results Expected

OD-0765657
Apr 15
CT.gov
00%
4d
ORKAPhase 2

ORKA-001 Induction Dose Phase 2 Results Expected

ORKA-001 Induction Dose80
Apr 15
CT.gov
00%
4d
ABVXPhase 3

ABX464 Phase 3 Results Expected

ABX4641,116
Apr 15
CT.gov
00%
2w
NVSEFPhase 3

Ianalumab Phase 3 Results Expected

Ianalumab226
Apr 24
CT.gov
00%
3w
TLSAPhase 2

Foralumab TZLS-401 100 µg Phase 2 Results Expected

Foralumab TZLS-401 100 µg55
Apr 30
CT.gov
00%
3w
AZNCFPhase 2

Tozorakimab Phase 2 Results Expected

Tozorakimab98
Apr 30
CT.gov
00%
3w
NVSPhase 3

Remibrutinib Phase 3 Results Expected

Remibrutinib1,011
Apr 30
CT.gov
00%
Pipeline by Phase
Phase 3
107
Related Conditions
autoimmunerheumatoid arthritislupuspsoriasiscrohnulcerative colitisibdinflammatoryimmuneimmunologyeczemadermatitisankylosing spondylitismultiple sclerosisgrafttransplantrejectionallergyasthma